Skip to main content
Premium Trial:

Request an Annual Quote

Waters Q3 Revenues Rise 11 Percent

NEW YORK – Waters reported on Tuesday that its revenues in the third quarter were up 11 percent.

The firm posted revenues of $659.2 million in Q3 compared to $593.8 million in Q3 2020 and beating the average Wall Street estimate of $656.5 million. Waters said that foreign currency translation boosted sales growth by less than 1 percent in the quarter.

The company said that sales in the pharmaceutical market increased 16 percent, sales in the industrial market increased 9 percent, and sales in the academic and government markets decreased 9 percent.

In a statement, Waters CEO Udit Batra said the company saw double-digit growth in instrument sales and recurring revenues.

The Milford, Massachusetts-based company posted a Q3 net profit of $161.2 million, or $2.60 per share, compared to a net profit of $126.8 million, or $2.03 per share, for Q3 2020. On a non-GAAP basis, Waters had EPS of $2.66, beating analysts' average estimate of $2.35.

The firm's R&D spending was up 20 percent year over year to $42.0 million from $35.0 million, while SG&A costs were up 13 percent to $152.5 million from $135.4 million.

The company ended the quarter with $655.2 million in cash, cash equivalents, and investments.

Waters provided a full-year 2021 guidance of revenue growth in the range of 15 percent to 16 percent, and non-GAAP EPS between $10.94 and $11.04. It expects Q4 2021 sales growth between 5 percent and 7 percent and non-GAAP EPS between $3.40 and $3.50.

In Tuesday morning trading on the New York Stock Exchange, shares of Waters were down 4 percent to $350.26.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.